Bartlett & Co’s NEVRO CORP. NVRO Stock Holding History

Bartlett & Co’s Portfolio NVRO Stock Details NVRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-1	Closed	–	–	1084
2021 Q2	$0	Hold	1	–	–	﹤0.01%	1085
2021 Q1	$0	Hold	1	–	–	﹤0.01%	1188
2020 Q4	$0	Buy	+1	New	+$162	﹤0.01%	1205

Other funds holding NVRO

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Bartlett & Co's NVRO Position: Q3 2021 in Review

Bartlett & Co sold out of NEVRO CORP. (NVRO) in Q3 2021, closing a stake of 1 share.

Bartlett & Co first reported a position in NVRO in Q4 2020 and held it in 3 quarters. The position peaked at $0 in Q2 2021. 194 funds tracked by Wall St. Rank hold NVRO as of Q3 2021.

Bartlett & Co reported no remaining NEVRO CORP. position as of Q3 2021 after selling out during the quarter.
Bartlett & Co sold 1 NEVRO CORP. share in Q3 2021.
Bartlett & Co first reported a position in NEVRO CORP. in Q4 2020 and held it in 3 quarters.
Bartlett & Co's NEVRO CORP. position peaked at $0 in Q2 2021.
194 funds tracked by Wall St. Rank held NEVRO CORP. as of Q3 2021.

Based on Bartlett & Co's 13F filing for Q3 2021, filed 15 Oct 2021.